Q3 2018 Holdings
Filed 2018-11-14 | 113 holdings | $76.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $378.0K | 40,000 | 0.5% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $462.0K | 1,419 | 0.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $1.7M | 95,300 | 2.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.8M | 321,430 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.5M | 40,000 | 4.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.0M | 240,000 | 5.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.3M | 233,151 | 5.6% |
| Cisco SYS Inc(CSCO) | COM | 17275R102 | $4.9M | 100,000 | 6.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $6.6M | 92,673 | 8.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.5M | 88,000 | 11.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.3M | 136,381 | 13.5% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $12.6M | 447,970 | 16.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $15.8M | 1,142,089 | 20.6% |